about
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish su...
Read More
8.10
-0.38
(-4.48%)
6.2M
XNAS Volume
XNAS 17 Oct, 2025 5:30 PM (EDT)
Medium Financial Strength
Affordable Valuation
Technically Neutral
Mid-range Performer
These stocks may be affordable or expensive, based on their medium quality and mid-range technical score. However, their reasonable financials are successful in gathering some investor interest.
View Similar
Embed DVM
Novavax Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..